NLRP3 and metabolic syndrome: In both obese murine models and human liver tissues, enhanced expression of NLRP3 inflammasome components, increased CASPASE‐1 activity, and elevated levels of IL‐1β have been observed, correlating directly with the severity of metabolic syndrome phenotypes (Ives et al. 2015).